255 related articles for article (PubMed ID: 3440096)
1. Differences in the binding of quinine and quinidine to plasma proteins.
Mihaly GW; Ching MS; Klejn MB; Paull J; Smallwood RA
Br J Clin Pharmacol; 1987 Dec; 24(6):769-74. PubMed ID: 3440096
[TBL] [Abstract][Full Text] [Related]
2. Comparison of disposition parameters of quinidine and quinine in the rat.
Watari N; Wakamatsu A; Kaneniwa N
J Pharmacobiodyn; 1989 Oct; 12(10):608-15. PubMed ID: 2630631
[TBL] [Abstract][Full Text] [Related]
3. New insight into the stereoselective interactions of quinine and quinidine, with bovine serum albumin.
Liu Y; Chen M; Wang S; Lin J; Cai L; Song L
J Mol Recognit; 2014 May; 27(5):239-49. PubMed ID: 24700591
[TBL] [Abstract][Full Text] [Related]
4. Plasma protein binding of quinine: binding to human serum albumin, alpha 1-acid glycoprotein and plasma from patients with malaria.
Wanwimolruk S; Denton JR
J Pharm Pharmacol; 1992 Oct; 44(10):806-11. PubMed ID: 1360505
[TBL] [Abstract][Full Text] [Related]
5. Capillary electrophoretic separation, immunochemical recognition and analysis of the diastereomers quinine and quinidine and two quinidine metabolites in body fluids.
Zaugg S; Thormann W
J Pharm Biomed Anal; 2001 Mar; 24(5-6):785-99. PubMed ID: 11248471
[TBL] [Abstract][Full Text] [Related]
6. Relative to quinine and quinidine, their 9-epimers exhibit decreased cytostatic activity and altered heme binding but similar cytocidal activity versus Plasmodium falciparum.
Gorka AP; Sherlach KS; de Dios AC; Roepe PD
Antimicrob Agents Chemother; 2013 Jan; 57(1):365-74. PubMed ID: 23114754
[TBL] [Abstract][Full Text] [Related]
7. Effect of Plasmodium falciparum malaria infection on the plasma concentration of alpha 1-acid glycoprotein and the binding of quinine in Malawian children.
Mansor SM; Molyneux ME; Taylor TE; Ward SA; Wirima JJ; Edwards G
Br J Clin Pharmacol; 1991 Sep; 32(3):317-21. PubMed ID: 1777367
[TBL] [Abstract][Full Text] [Related]
8. Factors affecting quinidine protein binding in humans.
Edwards DJ; Axelson JE; Slaughter RL; Elvin AT; Lalka D
J Pharm Sci; 1984 Sep; 73(9):1264-7. PubMed ID: 6491948
[TBL] [Abstract][Full Text] [Related]
9. Influence of the ORM1 phenotypes on serum unbound concentration and protein binding of quinidine.
Li JH; Xu JQ; Cao XM; Ni L; Li Y; Zhuang YY; Gong JB
Clin Chim Acta; 2002 Mar; 317(1-2):85-92. PubMed ID: 11814462
[TBL] [Abstract][Full Text] [Related]
10. Increased plasma binding of quinidine after surgery: a preliminary report.
Fremstad D; Bergerud K; Haffner JF; Lunde PK
Eur J Clin Pharmacol; 1976; 10(6):441-4. PubMed ID: 63371
[TBL] [Abstract][Full Text] [Related]
11. Perioperative variability of binding of lidocaine, quinidine, and propranolol after cardiac operations.
Davies RF; Dubé LM; Mousseau N; McGilveray I; Beanlands DS
J Thorac Cardiovasc Surg; 1988 Oct; 96(4):634-41. PubMed ID: 3172810
[TBL] [Abstract][Full Text] [Related]
12. Binding and displacement of basic, acidic and neutral drugs in normal and orosomucoid-deficient plasma.
Pike E; Skuterud B; Kierulf P; Fremstad D; Abdel Sayed SM; Lunde PK
Clin Pharmacokinet; 1981; 6(5):367-74. PubMed ID: 7333058
[TBL] [Abstract][Full Text] [Related]
13. Clinical oral doses of dexamethasone decreases intrinsic clearance of quinidine, a cytochrome P450 3A substrate in dogs.
Zhang K; Kohno S; Kuroha M; Kokue E; Shimoda M
J Vet Med Sci; 2006 Sep; 68(9):903-7. PubMed ID: 17019057
[TBL] [Abstract][Full Text] [Related]
14. The influence of alpha 1-acid glycoprotein on quinine and quinidine disposition in the rat isolated perfused liver preparation.
Mansor SM; Ward SA; Edwards G; Hoaksey PE; Breckenridge AM
J Pharm Pharmacol; 1991 Sep; 43(9):650-4. PubMed ID: 1685525
[TBL] [Abstract][Full Text] [Related]
15. Contribution of plasma proteins, albumin and alpha 1-acid glycoprotein, to pharmacokinetics of a multi-targeted receptor tyrosine kinase inhibitor, sunitinib, in analbuminemic rats.
Toyama Y; Ueyama J; Nomura H; Tsukiyama I; Saito H; Hisada T; Matsuura K; Hasegawa T
Anticancer Res; 2014 May; 34(5):2283-9. PubMed ID: 24778032
[TBL] [Abstract][Full Text] [Related]
16. Determinants of carbamazepine and carbamazepine 10,11-epoxide binding to serum protein, albumin and alpha 1-acid glycoprotein.
MacKichan JJ; Zola EM
Br J Clin Pharmacol; 1984 Oct; 18(4):487-93. PubMed ID: 6487490
[TBL] [Abstract][Full Text] [Related]
17. Distribution of moricizine in human blood: binding to plasma proteins and erythrocytes.
Yang JM; Chan K; Chiang WT
Ther Drug Monit; 1990 Jan; 12(1):59-64. PubMed ID: 1689514
[TBL] [Abstract][Full Text] [Related]
18. Melatonin high-affinity binding to alpha-1-acid glycoprotein in human serum.
Morin D; Simon N; Deprés-Brummer P; Lévi F; Tillement JP; Urien S
Pharmacology; 1997 May; 54(5):271-5. PubMed ID: 9380773
[TBL] [Abstract][Full Text] [Related]
19. Gallopamil binding to human serum proteins.
Rutledge DR; Pieper JA
Eur J Clin Pharmacol; 1987; 33(4):375-80. PubMed ID: 3443143
[TBL] [Abstract][Full Text] [Related]
20. Binding of quinidine in sera with different levels of triglycerides, cholesterol, and orosomucoid protein.
Nilsen OG; Leren P; Aakesson I; Jacobsen S
Biochem Pharmacol; 1978 Mar; 27(6):871-6. PubMed ID: 656136
[No Abstract] [Full Text] [Related]
[Next] [New Search]